Research Article
BibTex RIS Cite

Evaluation of the renoprotective effect of Embelia tserjiam-cottam fruits in a rat model of diabetic kidney disease

Year 2024, Volume: 28 Issue: 5, 1691 - 1703, 28.06.2025

Abstract

The objective of the present study was to determine the renoprotective activity of Embelia tserjiam-cottam fruit extract in a streptozotocin-induced model of diabetic nephropathy in rats. The renoprotective effect of the ethanolic extract of Embelia tserjiam-cottam (EET) fruit (200mg/kg BW and 400 mg/kg BW) was studied by measuring blood glucose levels, body weight, kidney hypertrophy, serum and urine creatinine, urine microalbumin, blood urea nitrogen (BUN) and glycosylated hemoglobin (HbA1C) levels. Levels of enzymes like malondialdehyde (MDA), superoxide dismutase (SOD), glutathione reductase (GSH), and catalase was also measured. Renal histopathology studies were carried out. Treatment with the high dose of EET 400mg/kg BW caused a significant decrease (p

References

  • [1] Lin Y, Chang Y, Yang S, Wu K, Chu T. Update of pathophysiology and management of diabetic kidney disease. J Formos Med Assoc. 2018;117(8):662–75. https: //doi.org/10.1016/j.jfma.2018.02.007
  • [2]Mestry SN, Dhodi JB, Kumbhar SB, Juvekar AR. Attenuation of diabetic nephropathy in streptozotocin-induced diabetic rats by Punica granatum Linn. leaves extract. J Tradit Complement Med. 2017;7(3):273–80. https://doi.org/10.1016/j.jtcme.2016.06.008 [3] Brownlee M. The Pathobiology of Diabetic Complications A Unifying Mechanism. Diabetes 2005;54:1615–25. https://doi.org/10.2337/diabetes.54.6.1615
  • [4] Mitra R, Goyal P. Diabetic Nephropathy : A Review of Pathophysiological mechanisms, Therapeutic interventions and Biomarkers. Int J Pharm Res. 2020;12(1):419–26. https://doi.org/10.31838/ijpr/2020.12.01.083
  • [5] Schena FP, Gesualdo L. Pathogenetic Mechanisms of Diabetic Nephropathy. J Am Soc Nephrol 2005;16:S30–3. https://doi.org/10.1681/asn.2004110970
  • [6] Sharma S, Anjaneyulu M, Chopra K, Kulkarni S. Resveratrol, a Polyphenolic Phytoalexin, Attenuates Diabetic Nephropathy in Rats. Pharmacology. 2006;76:69–75. https://doi.or10.1159/000089720 [7] Kashihara N, Haruna Y, Kondeti V, Kanwar Y. Oxidative stress in diabetic nephropathy. Curr Med Chem. 2010;17(34):4256–69. https://doi.org/10.2174/092986710793348581
  • [8] Dodda D, Ciddi V. Plants Used in the Management of Diabetic Complications. Indian J Pharm Sci. 2014;76(2):97 106. https://doi.org/10.4103/0250-474X.131518
  • [9]Nasri H, Ardalan M, Rafieian-kopaei M. Mechanistic Impacts of Medicinal Plants in Diabetic Kidney Disease. Iran J Public Health. 2014;43(9):1311–3. [10]
  • Dragos D, Manea MM, Timofte D, Ionescu D. Mechanisms of Herbal Nephroprotection in diabetes mellitus. J of Diabetes Res. 2020; 2020:5710513. https://doi.org/10.1155/2020/5710513
  • [11] Al-waili N, El-waili H, Al-waili T, Salom K. Natural antioxidants in the treatment and prevention of diabetic nephropathy ; a potential approach that warrants clinical trials. Redox Rep. 2017;22(3):99–118. https://doi.org/10.1080/13510002.2017.1297885
  • [12] Naik SR, Niture NT, Ansari AA, Shah PD. Anti-diabetic activity of embelin: Involvement of cellular inflammatory mediators, oxidative stress and http://doi.org/10.1016/j.phymed.2013.03.003 other biomarkers. Phytomedicine 2013;20(10):797-804.
  • [13] Deshpande RR, Kulkarni A, Jadhav M, Mahajan P, Patil D, Varghese V, Gaikwad SA, Nirmala R, Screening of antimicrobial activity of herbal extract of Embelia Basal, Chlorhexidine & Amoxicillin against salivary microflora of mixed dentition age group. J Appl Pharm Sci. 2012;02(01):70–2.
  • [14] Chitra M, Sukumar E, Suja V, Shyamala Devi C. Antitumor, Anti-Inflammatory and Analgesic property of Embelin, a Plant Product. Exp Chemother. 1994;40:109–13. https://doi.org/10.1159/000239181
  • [15] Thorat K, Pokhriyal B, Patil L, Limaye D, Kadam V. Antimicrobial activity of extracts of leaf and roots of Embelia tserjiam cottam against dental pathogens. Int J Compr Pharm. 2012;3(3).
  • [16] Singh D, Singh R, Singh P, Gupta RS. Effects of Embelin on Lipid Peroxidation and Free Radical Scavenging Activity against Liver Damage in Rats. Basic Clin Pharmacol Toxicol. 2009;105:243–8. https://doi.org/10.1111/j.1742-7843.2009.00429.x
  • [17] Somanadhan B, Varughese G, Palpu P, Sreedharan R, Gudiksen L, Smitt UW, Nyman U. An ethnopharmacological survey for potential angiotensin converting enzyme inhibitors from Indian medicinal plants. 1999;65:103–12. https://doi.org/10.1016/s0378-8741(98)00201-3
  • [18] Goyal P, Mittal P. Pharmacognostical and pharmacological review on Crinum latifolium, plant cell bıotechnology and molecular bıology, 2020; 21(17-18):207-211.
  • [19] Bharti A, Mittal P, Bora KS. Neurotrophic Factors as Antiapoptotic Agents – A Review. Research Journal of Pharmacy and Technology. 2022; 15(11):5327-0. doi: 10.52711/0974-360X.2022.00897
  • [20] Joshua O, Chen H, Zhou Y. Lycium chinense leaves extract ameliorates diabetic nephropathy by suppressing hyperglycemia mediated renal oxidative stress and inflammation. Biomed Pharmacother. 2018;102:1145–51. https://doi.org/10.1016/j.biopha.2018.03.037
  • [21] Omara EA, Nada SA, Farrag ARH, Sharaf WM, El-Toumy SA. Therapeutic effect of Acacia nilotica pods extract on streptozotocin induced diabetic nephropathy in rat. Phytomedicine 2012;19(12):1059–67. https://doi.org/10.1016/j.phymed.2012.07.006
  • [22] Mitra R, Mazumder PM, Sasmal D. Comparative evaluation of the efficacy of some ayurvedic formulations in attenuating the progression of diabetic nephropathy. Pharmacologyonline 2010;1:709–17. https://doi.org/10.1111/j.1742-7843.2009.00429.x
  • [23] Kaur R, Sodhi RK, Aggarwal N, Kaur J, Jain UK. Renoprotective effect of lansoprazole in streptozotocin-induced diabetic nephropathy in wistar rats. Naunyn-Schmiedeberg’s Arch Pharmacol. 2016;1:73–85. https://doi.org/10.1007/s00210-015-1182-6
  • [24] Bonsnes RW, Taussky HH. On the colorimetric determination of creatinine by the jaffe reaction. J Biol Chem. 158(3):581–91. https://doi.org/10.1016/S0021-9258(19)51334-5
  • [25] Delanghe JR, Speeckaert MM. Creatinine determination according to Jaffe — what does it stand for ? NDT Plus. 2011;4:83–6. https://doi.org/10.1093/ndtplus/sfq211
  • [26] Webster D. The immediate reaction between bromcresol green and serum as a measure of albumin content. Clin Chem. 1977;23(4):663-5.
  • [27] Grover J, Yadav S, Vats V. Effect of feeding Murraya koeingii and Brassica juncea diet on kidney function in streptozotocin diabetic mice. J Ethnopharmacol. 2003;85:1–5. https://doi.org/10.1016/s0378-8741(02)00355-0
  • [28] Kareem I, Jaweed SA, Bardapurkar JS, Patil V. Study of Magnesium, Glycosylated hemoglobin and lipid profile in diabetic retinopathy. Indian J Clin Biochem. 2004;19(2):124–7. https://doi.org/10.1007/BF02894270
  • [29] Ohkawa H, Ohishi N YK. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351–8. https://doi.org/10.1016/0003-2697(79)90738-3
  • [30] Ray A, Chaudhuri SR, Majumdar B, Bandyopadhyay SK. Antioxidant activity of ethanol extract of rhizome of picrorhiza kurroa on indomethacin induced gastric ulcer during healing. Indian J Clin Biochem. 2002;17(2):44–51. https://doi.org/10.1007/BF02867970 [
  • 31] Kono Y. Generation of Superoxide Radical during Autoxidation of Hydroxylamine and an Assay for Superoxide Dismutase. Arch Biochem Biophys. 1978;186(1):189–95. https://doi.org/10.1016/0003-9861(78)90479-4
  • [32] Ellman GL. Tissue Sulfhydryl Groups. Arch Biochem Biophys. 1959;82:70–7. https://doi.org/10.1016/0003 9861(59)90090-6
  • [33] Soldatos G, Cooper ME. Diabetic nephropathy : Important pathophysiologic mechanisms. Diabetes Res Clin Pract. 2008;82:S75–9. https://doi.org/10.1016/j.diabres.2008.09.042
  • [34] Raval N, Kumawat A, Kalyane D, Kalia K, Tekade RK. Understanding molecular upsets in diabetic nephropathy to identify novel targets and treatment opportunities. Drug Discov Today 2020;25(5):862–78. https://doi.org/10.1016/j.drudis.2020.01.008
  • [35] Yokogawa T, Nakagawa T, Wakaki K, Koizumi F. Animal model of diabetic nephropathy. Exp Toxicol Pathol. 2001;53:359–63. https://doi.org/10.1078/0940-2993-00203
  • [36] Amorim RG, Guedes S, Mary S, Vasconcelos DL, Célia J, Santos DF. Kidney Disease in Diabetes Mellitus : Cross Linking between Hyperglycemia , Redox Imbalance and Inflammation. Arq Bras Cardiol. 2019;112(5):577–87. https://doi.org/10.5935/abc.20190077 [37] Nathan D, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med. 1993;329(14):977–86. https://doi.org/10.1056/nejm199309303291401
  • [38] Dabla PK. Renal function https://doi.org/10.4239/wjd.v1.i2.48 in diabetic nephropathy. World J Diabetes. 2010;1(2):48–56.
  • [39] Wang GG, Lu XH, Li W, Zhao X, Zhang C. Protective Effects of Luteolin on Diabetic Nephropathy in STZ-Induced Diabetic Rats. Evidence-based Complement Altern Med. 2011;2011:1–7. https://doi.org/10.1155/2011/323171
  • [40] Rabkin R, Fervenza FC. Renal Hypertrophy and Kidney Disease in Diabetes. Diabetes Metab Rev. 1996;12(3):217 41. https://doi.org/10.1002/(SICI)1099-0895(199610)12:33.0.CO;2-C
  • [41] Roshan B, Stanton R. A story of microalbuminuria and diabetic nephropathy. J Nephropathol. 2013;2(4):234–40. https://doi.org/10.12860/jnp.2013.37
  • [42] Stratton M, Adler A, Neil H, Matthews D, Manley S, Cull C, Hadden D, Turner RC, Rury R. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes ( UKPDS 35 ) : prospective observational study. Br Med J. 2000;321:405–12. https://doi.org/10.1136/bmj.321.7258.405 [43] Vasavada N, Agarwal R. Role of Oxidative Stress in Diabetic Nephropathy. Adv Chronic Kidney Dis. 2005;12(2):146–54. https://doi.org/10.1053/j.ackd.2005.01.001
  • [44] Thomas MC, Brownlee M, Susztak K, Sharma K, Jandeleit-dahm KAM, Zoungas S, Rossing P, Grup PH, Cooper ME. Diabetic kidney disease. Nat Rev Dis Prim. 2015;1:1–20. https://doi.org/10.1038/nrdp.2015.18
  • [45] G KK, Dhamotharan R, Kulkarni NM, Honnegowda S, Murugesan S. Embelin ameliorates dextran sodium sulfate induced colitis in mice. Int Immunopharmacol 2011;11(6):724–31. https://doi.org/10.1016/j.intimp.2011.01.022
  • [46] Poojari R. Embelin-a drug of antiquity : Shifting the paradigm towards modern medicine. Expert Opin Investig Drugs. 2014;23(3):427–44. https://doi.org/10.1517/13543784.2014.867016
There are 42 citations in total.

Details

Primary Language English
Subjects Pharmacology and Pharmaceutical Sciences (Other)
Journal Section Articles
Authors

Reema Mitra 0000-0001-8436-786X

Payal Mittal 0000-0001-5336-3479

Pradeep Goyal 0000-0003-1800-8759

Publication Date June 28, 2025
Published in Issue Year 2024 Volume: 28 Issue: 5

Cite

APA Mitra, R., Mittal, P., & Goyal, P. (2025). Evaluation of the renoprotective effect of Embelia tserjiam-cottam fruits in a rat model of diabetic kidney disease. Journal of Research in Pharmacy, 28(5), 1691-1703.
AMA Mitra R, Mittal P, Goyal P. Evaluation of the renoprotective effect of Embelia tserjiam-cottam fruits in a rat model of diabetic kidney disease. J. Res. Pharm. July 2025;28(5):1691-1703.
Chicago Mitra, Reema, Payal Mittal, and Pradeep Goyal. “Evaluation of the Renoprotective Effect of Embelia Tserjiam-Cottam Fruits in a Rat Model of Diabetic Kidney Disease”. Journal of Research in Pharmacy 28, no. 5 (July 2025): 1691-1703.
EndNote Mitra R, Mittal P, Goyal P (July 1, 2025) Evaluation of the renoprotective effect of Embelia tserjiam-cottam fruits in a rat model of diabetic kidney disease. Journal of Research in Pharmacy 28 5 1691–1703.
IEEE R. Mitra, P. Mittal, and P. Goyal, “Evaluation of the renoprotective effect of Embelia tserjiam-cottam fruits in a rat model of diabetic kidney disease”, J. Res. Pharm., vol. 28, no. 5, pp. 1691–1703, 2025.
ISNAD Mitra, Reema et al. “Evaluation of the Renoprotective Effect of Embelia Tserjiam-Cottam Fruits in a Rat Model of Diabetic Kidney Disease”. Journal of Research in Pharmacy 28/5 (July 2025), 1691-1703.
JAMA Mitra R, Mittal P, Goyal P. Evaluation of the renoprotective effect of Embelia tserjiam-cottam fruits in a rat model of diabetic kidney disease. J. Res. Pharm. 2025;28:1691–1703.
MLA Mitra, Reema et al. “Evaluation of the Renoprotective Effect of Embelia Tserjiam-Cottam Fruits in a Rat Model of Diabetic Kidney Disease”. Journal of Research in Pharmacy, vol. 28, no. 5, 2025, pp. 1691-03.
Vancouver Mitra R, Mittal P, Goyal P. Evaluation of the renoprotective effect of Embelia tserjiam-cottam fruits in a rat model of diabetic kidney disease. J. Res. Pharm. 2025;28(5):1691-703.